Zaccagni Hayden J, Alten Jeffrey A, Cleveland David C, Tyler Argent R, Law Mark A, Bryant Ayesha S, Borasino Santiago
Section of Pediatric Cardiac Critical Care Medicine, University of Alabama at Birmingham, 1700 6th Avenue South, Suite 9100, Birmingham, AL, 35233, USA.
Division of Pediatric Cardiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Pediatr Cardiol. 2016 Oct;37(7):1278-83. doi: 10.1007/s00246-016-1429-0. Epub 2016 Jun 9.
The Fontan operation has low mortality, but is associated with significant postoperative morbidity, including prolonged chest tube output (PCTO), which is associated with prolonged hospital length of stay (PLOS). We sought to identify variables present early in the clinical course that could predict patients at high risk for PCTO and PLOS. Retrospective data were collected on 84 Fontan (extracardiac conduit) operations from 1/2008 to 12/2013 at a single institution. PCTO was defined as ≥8 days (>75th percentile); PLOS was defined as ≥12 days postoperatively (>75th percentile). Multivariate regression was used to determine covariates associated with PCTO and PLOS. Median age was 3.5 years (IQR 3-5); weight was 14.5 kg (IQR 13-17). There was no mortality. LOS was 9 days (IQR 3-11), and duration of chest tube drainage 6 days (IQR 5-8) at 15 ml/kg/day (IQR 9-20). In univariate analysis, only systemic right ventricle, 24-h 5 % albumin administration, 24-h fluid balance, and 12-h inotrope score were associated with PCTO. In multivariate analysis, only 5 % albumin administration in first 24 h (p < 0.001) and PCTO were independently associated with PLOS. ROC curve analysis showed patients receiving >25 ml/kg of 5 % albumin in first 24-h predicted PLOS (94 % specificity, 93 % sensitivity, AUC = 0.95, p < 0.001). Increased colloid in the first 24-h post-CPB strongly predicts PCTO and PLOS after Fontan operation, potentially providing an early identification of a cohort with unfavorable Fontan physiology. A better understanding of the role of colloid resuscitation after Fontan is necessary, and efforts to reduce perioperative colloid administration could decrease hospital morbidity.
Fontan手术死亡率较低,但术后并发症发生率较高,包括胸腔引流管引流时间延长(PCTO),这与住院时间延长(PLOS)相关。我们试图确定临床病程早期出现的可预测PCTO和PLOS高风险患者的变量。收集了2008年1月至2013年12月在一家机构进行的84例Fontan(心外管道)手术的回顾性数据。PCTO定义为≥8天(>第75百分位数);PLOS定义为术后≥12天(>第75百分位数)。采用多变量回归确定与PCTO和PLOS相关的协变量。中位年龄为3.5岁(四分位间距3 - 5岁);体重为14.5千克(四分位间距13 - 17千克)。无死亡病例。住院时间为9天(四分位间距3 - 11天),胸腔引流管引流时间为6天(四分位间距5 - 8天),引流量为15毫升/千克/天(四分位间距9 - 20毫升/千克/天)。单变量分析中,仅体循环右心室、24小时内给予5%白蛋白、24小时液体平衡和12小时血管活性药物评分与PCTO相关。多变量分析中,仅术后首24小时给予5%白蛋白(p < 0.001)和PCTO与PLOS独立相关。ROC曲线分析显示,术后首24小时接受>25毫升/千克5%白蛋白的患者可预测PLOS(特异性94%,敏感性93%,AUC = 0.95,p < 0.001)。体外循环后首24小时胶体量增加强烈预测Fontan手术后的PCTO和PLOS,这可能有助于早期识别具有不良Fontan生理学特征的患者群体。有必要更好地理解Fontan手术后胶体复苏的作用,努力减少围手术期胶体的使用可能会降低医院并发症发生率。